ClinicalTrials.govrestricted

Rigosertib Plus Pembrolizumab in Treating Patients With Unresectable/Metastatic Melanoma Refractory to PD-1 Inhibitors

ClinicalTrials.gov study NCT05764395. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.

ShareScore

24/100

Overall dataset sharing score

Score breakdown

These five areas show where the dataset supports — or may limit — practical reuse.

Stewardship: 12
Harmonization: 8
Access: 0
Reuse readiness: 0
Engagement: 4

Topics

clinical trial NIH ClinicalTrials.gov

Dataset details

Repository: ClinicalTrials.gov
Published: February 11, 2026
License: IPD-UNDECIDED
DOI: clinicaltrials.gov/NCT05764395

Scored with release 0.9.0

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

Start your CV How the NIH biosketch works